BioCryst Pharmaceuticals Form 4 Filings Shows CCO Charles K Gayer Bought 30,000 Shares At An Average Price Of $5.47/Share; CEO Jon P Stonehouse Bought 30,000 Shares At An Average Price Of $5.55/Share; Steven K Galson Bought 21,940 Shares At An Average...
BioCryst Pharmaceuticals Form 4 Filings Shows CCO Charles K Gayer Bought 30,000 Shares At An Average Price Of $5.47/Share; CEO Jon P Stonehouse Bought 30,000 Shares At An Average Price Of $5.55/Share; Steven K Galson Bought 21,940 Shares At An Average...
BioCryst Pharmicals表格4文件显示,首席运营官查尔斯·盖尔以平均每股5.47美元的价格购买了3万股股票;首席执行官乔恩·斯通豪斯以每股5.55美元的平均价格购买了3万股股票;史蒂芬·加尔森平均购买了21,940股股票...
BioCryst Pharmaceuticals Form 4 Filings Shows CCO Charles K Gayer Bought 30,000 Shares At An Average Price Of $5.47/Share; CEO Jon P Stonehouse Bought 30,000 Shares At An Average Price Of $5.55/Share; Steven K Galson Bought 21,940 Shares At An Average Price Of $5.49/Share; Helen M. Thackray Bought 30,000 Shares At An Average Price Of $5.86/Share; Anthony Doyle Bought 36,300 Shares At An Average Price Of $5.57/Share
BioCryst Pharmicals表格4文件显示,首席运营官查尔斯·盖尔以平均每股5.47美元的价格购买了3万股股票;首席执行官乔恩·斯通豪斯以每股5.55美元的平均价格购买了3万股股票;史蒂芬·加尔森以平均每股5.49美元的价格购买了21,940股股票;海伦·萨克雷以每股5.86美元的平均价格购买了3万股股票;安东尼·道尔购买了36,300股股票平均价格为每股5.57美元
- SEC Filing
-美国证券交易委员会备案